Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02819843
Title	A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Memorial Sloan Kettering Cancer Center
Indications	Advanced Solid Tumor Merkel cell carcinoma melanoma
Therapies	Talimogene laherparepvec
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 3 of 3 entries

Facility	City	State	Zip	Country	Details
Memorial Sloan Kettering Cancer Center	New York	New York	10065	United States	Details
Memorial Sloan Kettering Monmouth	Middletown	New Jersey	07748	United States	Details
Memorial Sloan Kettering Westchester	Harrison	New York	10604	United States	Details

Showing 1 to 3 of 3 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field